{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:21Z","timestamp":1792786101626,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Association \u2018Recherche en M\u00e9decine Interne et en Immunologie Clinique\u2019"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a rare disease that may be associated with CTD. Anti-fibroblast (AFA) and AECA have been identified in idiopathic and SSc-associated PAH. The aim was to identify autoantibodies discriminating for PAH associated with SLE, MCTD and primary SS, and their target antigens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sera were collected in the French multicentre auto-HTAP study from 86 patients with CTD excluding SSc, including 32 with PAH (PAH+) and 54 without (PAH\u2212). AFA and AECA were identified using one- (1D) and two-dimensional (2D) immunoblots and proteomics. ELISA tests using human recombinant proteins were used to confirm PAH-associated IgG reactivities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PAH+ patients had similar IgG AFA and AECA reactivities in 56.2% and 40.6% of the cases in 1D immunoblots, respectively. In 2D immunoblots, serum IgG pools from SLE patients (n\u2009=\u200914), MCTD (n\u2009=\u200910), SS (n\u2009=\u20099) and 14 healthy controls (n\u2009=\u20091) recognized, respectively, 273\u2009\u00b1\u200979, 205\u2009\u00b1\u200977, 109\u2009\u00b1\u200911 and 109 protein spots in fibroblasts and 189\u2009\u00b1\u200948, 146\u2009\u00b1\u200930, 88\u2009\u00b1\u200933 and 190 protein spots in endothelial cell extracts. Serum IgG from PAH+ patients recognized 39 fibroblast and 34 endothelial cell protein spots that were not recognized by IgG from PAH\u2212 patients, including Annexin A5 (ANXA5). Anti-ANXA5 IgG reactivity was significantly higher in PAH+ compared with PAH\u2212 patients with MCTD (73% vs 0%, P &amp;lt; 0.001) and SLE (33% vs 0%, P = 0.009).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-ANXA5 IgG autoantibody reactivity might represent a predictive biomarker for PAH associated with MCTD and SLE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf075","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T15:20:13Z","timestamp":1738768813000},"page":"4041-4050","source":"Crossref","is-referenced-by-count":5,"title":["Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-4524","authenticated-orcid":false,"given":"Benjamin","family":"Thoreau","sequence":"first","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris,","place":["France"]},{"name":"CNRS UMR 8104, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]},{"name":"Service de M\u00e9decine interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes et Autoinflammatoires Syst\u00e9miques Rares d'Ile de France, de l\u2019Est et de l\u2019Ouest, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP) , Paris,","place":["France"]},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8029-9417","authenticated-orcid":false,"given":"Arthur","family":"Renaud","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris,","place":["France"]},{"name":"CNRS UMR 8104, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]},{"name":"Service de M\u00e9decine interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes et Autoinflammatoires Syst\u00e9miques Rares d'Ile de France, de l\u2019Est et de l\u2019Ouest, CHU de Nantes , Nantes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chafey","sequence":"additional","affiliation":[{"name":"Proteom\u2019IC Facility, Universit\u00e9 Paris Cit\u00e9, CNRS, Inserm, Institut Cochin , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Clary","sequence":"additional","affiliation":[{"name":"Proteom\u2019IC Facility, Universit\u00e9 Paris Cit\u00e9, CNRS, Inserm, Institut Cochin , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Le Gall","sequence":"additional","affiliation":[{"name":"Proteom\u2019IC Facility, Universit\u00e9 Paris Cit\u00e9, CNRS, Inserm, Institut Cochin , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Broussard","sequence":"additional","affiliation":[{"name":"Proteom\u2019IC Facility, Universit\u00e9 Paris Cit\u00e9, CNRS, Inserm, Institut Cochin , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-7247","authenticated-orcid":false,"given":"Odile","family":"Launay","sequence":"additional","affiliation":[{"name":"CIC Cochin Pasteur, H\u00f4pital Cochin, AP-HP, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-1817","authenticated-orcid":false,"given":"David","family":"Launay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North of France, North-West, Mediterranean and Guadeloupe (CeRAINOM) , Lille,","place":["France"]},{"name":"CHU Lille, Univ. Lille, Inserm, U1286 \u2013 INFINITE\u2014Institute for Translational Research in Inflammation , Lille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-847X","authenticated-orcid":false,"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Referral Centre for Centre for Rare Systemic Autoimmune Diseases North of France, North-West, Mediterranean and Guadeloupe (CeRAINOM) , Lille,","place":["France"]},{"name":"CHU Lille, Univ. Lille, Inserm, U1286 \u2013 INFINITE\u2014Institute for Translational Research in Inflammation , Lille,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Deligny","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine interne et Immunologie clinique, H\u00f4pital Pierre Zobda-Quitman, CHU de Martinique , Fort de France,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2548-7858","authenticated-orcid":false,"given":"Alban-Elouen","family":"Baruteau","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Pediatric Cardiac Surgery, FHU PRECICARE, Nantes Universit\u00e9, CHU Nantes , Nantes,","place":["France"]},{"name":"INSERM, CIC FEA 1413, Nantes Universit\u00e9, CHU Nantes , Nantes,","place":["France"]},{"name":"CNRS, INSERM, l\u2019institut du thorax, Nantes Universit\u00e9, CHU Nantes , Nantes,","place":["France"]},{"name":"INRAE, UMR 1280, PhAN, Nantes Universit\u00e9 , Nantes, F-44000,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Vallet-Pichard","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9patologie, Universit\u00e9 Paris Cit\u00e9, H\u00f4pital Cochin, AP-HP, INSERM U1223, Institut Pasteur , Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5448-7860","authenticated-orcid":false,"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris,","place":["France"]},{"name":"CNRS UMR 8104, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]},{"name":"Service de M\u00e9decine interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes et Autoinflammatoires Syst\u00e9miques Rares d'Ile de France, de l\u2019Est et de l\u2019Ouest, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP) , Paris,","place":["France"]},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzeddine","family":"Yaici","sequence":"additional","affiliation":[{"name":"AP-HP, INSERM UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, H\u00f4pital de Bic\u00eatre, Universit\u00e9 Paris\u2013Saclay , Le Kremlin Bic\u00eatre,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-1951","authenticated-orcid":false,"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[{"name":"AP-HP, INSERM UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, H\u00f4pital de Bic\u00eatre, Universit\u00e9 Paris\u2013Saclay , Le Kremlin Bic\u00eatre,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[{"name":"AP-HP, INSERM UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, H\u00f4pital de Bic\u00eatre, Universit\u00e9 Paris\u2013Saclay , Le Kremlin Bic\u00eatre,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2892","authenticated-orcid":false,"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[{"name":"AP-HP, INSERM UMR_S 999, Service de Pneumologie et Soins Intensifs Respiratoires, H\u00f4pital de Bic\u00eatre, Universit\u00e9 Paris\u2013Saclay , Le Kremlin Bic\u00eatre,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-246X","authenticated-orcid":false,"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris,","place":["France"]},{"name":"CNRS UMR 8104, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]},{"name":"Service de M\u00e9decine interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes et Autoinflammatoires Syst\u00e9miques Rares d'Ile de France, de l\u2019Est et de l\u2019Ouest, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP) , Paris,","place":["France"]},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 Paris Cit\u00e9 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"2025052703532867900_keaf075-B1","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"2025052703532867900_keaf075-B2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052703532867900_keaf075-B3","doi-asserted-by":"crossref","first-page":"103506","DOI":"10.1016\/j.autrev.2023.103506","article-title":"Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): recent and advanced data","volume":"23","author":"Thoreau","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2025052703532867900_keaf075-B4","doi-asserted-by":"crossref","first-page":"1801887","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"2025052703532867900_keaf075-B5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cvr\/cvz308","article-title":"Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator","volume":"116","author":"Huertas","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2025052703532867900_keaf075-B6","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052703532867900_keaf075-B7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201202-0335OC","article-title":"Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension","volume":"186","author":"Savai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052703532867900_keaf075-B8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/annrheumdis-2011-200195","article-title":"IgG from patients with pulmonary arterial hypertension and\/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction","volume":"71","author":"Bussone","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025052703532867900_keaf075-B9","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1183\/09031936.00181410","article-title":"Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma","volume":"39","author":"Dib","year":"2012","journal-title":"Eur Respir J"},{"key":"2025052703532867900_keaf075-B10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","article-title":"Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension","volume":"28","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"key":"2025052703532867900_keaf075-B11","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","article-title":"Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension","volume":"177","author":"Terrier","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052703532867900_keaf075-B12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025052703532867900_keaf075-B13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"2025052703532867900_keaf075-B14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension","volume":"11","author":"Herv\u00e9","year":"1998","journal-title":"Eur Respir J"},{"key":"2025052703532867900_keaf075-B15","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025052703532867900_keaf075-B16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"2025052703532867900_keaf075-B17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2025052703532867900_keaf075-B18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025052703532867900_keaf075-B19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2169\/internalmedicine.38.386","article-title":"Mixed connective tissue disease","volume":"38","author":"Kasukawa","year":"1999","journal-title":"Intern Med"},{"key":"2025052703532867900_keaf075-B20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2014an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"2025052703532867900_keaf075-B21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2025052703532867900_keaf075-B22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pmic.200700794","article-title":"Identification of target antigens of antiendothelial cell antibodies in healthy individuals: a proteomic approach","volume":"8","author":"Servettaz","year":"2008","journal-title":"Proteomics"},{"key":"2025052703532867900_keaf075-B23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1196\/annals.1398.060","article-title":"A combined SDS-PAGE and proteomics approach to identify target autoantigens in healthy individuals and patients with autoimmune diseases","volume":"1109","author":"Guilpain","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"2025052703532867900_keaf075-B24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V","article-title":"The current state of two-dimensional electrophoresis with immobilized pH gradients","volume":"21","author":"G\u00f6rg","year":"2000","journal-title":"Electrophoresis"},{"key":"2025052703532867900_keaf075-B25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Ishihama","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"2025052703532867900_keaf075-B26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1183\/09031936.00151313","article-title":"Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension","volume":"43","author":"Cracowski","year":"2014","journal-title":"Eur Respir J"},{"key":"2025052703532867900_keaf075-B27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","article-title":"Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension","volume":"185","author":"Perros","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052703532867900_keaf075-B28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor \u03b2 and Activate Fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis & Rheumatology (Hoboken, NJ)"},{"key":"2025052703532867900_keaf075-B29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/ATVBAHA.110.216747","article-title":"Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice","volume":"31","author":"Ewing","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025052703532867900_keaf075-B30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/aps.2014.61","article-title":"Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats","volume":"35","author":"Chen","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"2025052703532867900_keaf075-B31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2004.07.006","article-title":"Anti-annexin V antibodies: are they prothrombotic?","volume":"4","author":"Esposito","year":"2005","journal-title":"Autoimmun Rev"},{"key":"2025052703532867900_keaf075-B32","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2004-01-0203","article-title":"Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome","volume":"104","author":"Rand","year":"2004","journal-title":"Blood"},{"key":"2025052703532867900_keaf075-B33","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","article-title":"Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a \u201clupus procoagulant\u201d phenomenon","volume":"92","author":"Rand","year":"1998","journal-title":"Blood"},{"key":"2025052703532867900_keaf075-B34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42358-020-00140-w","article-title":"Anti-annexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study","volume":"60","author":"Horimoto","year":"2020","journal-title":"Adv Rheumatol"},{"key":"2025052703532867900_keaf075-B35","first-page":"2168","article-title":"Anti-annexin V antibodies and digital ischemia in patients with scleroderma","volume":"26","author":"Sugiura","year":"1999","journal-title":"J Rheumatol"},{"key":"2025052703532867900_keaf075-B36","first-page":"199","article-title":"Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury","volume":"23","author":"Assous","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2025052703532867900_keaf075-B37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.13752","article-title":"Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort","volume":"295","author":"Chevalier","year":"2024","journal-title":"J Intern Med"},{"key":"2025052703532867900_keaf075-B38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/CMAMD.S4503","article-title":"Anti-annexin v antibodies: association with vascular involvement and disease outcome in patients with systemic sclerosis","volume":"3","author":"Habeeb","year":"2010","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"2025052703532867900_keaf075-B39","doi-asserted-by":"crossref","first-page":"105236","DOI":"10.1016\/j.phrs.2020.105236","article-title":"14-3-3 modulation of the inflammatory response","volume":"163","author":"Munier","year":"2021","journal-title":"Pharmacol Res"},{"key":"2025052703532867900_keaf075-B40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cellsig.2016.12.007","article-title":"Extracellular functions of 14-3-3 adaptor proteins","volume":"31","author":"Kaplan","year":"2017","journal-title":"Cell Signal"},{"key":"2025052703532867900_keaf075-B41","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"2025052703532867900_keaf075-B42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yexcr.2005.05.002","article-title":"Comparison of early passage, senescent and hTERT immortalized endothelial cells","volume":"309","author":"Chang","year":"2005","journal-title":"Exp Cell Res"},{"key":"2025052703532867900_keaf075-B43","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1111\/ajt.15340","article-title":"Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss","volume":"19","author":"Louis","year":"2019","journal-title":"Am J Transplant"},{"key":"2025052703532867900_keaf075-B44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","article-title":"Endothelial-to-mesenchymal transition in pulmonary hypertension","volume":"131","author":"Ranchoux","year":"2015","journal-title":"Circulation"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf075\/61792877\/keaf075.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/4041\/61792877\/keaf075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/6\/4041\/61792877\/keaf075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T03:53:38Z","timestamp":1748318018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/6\/4041\/8005241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,2,7]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf075","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,2,7]]}}}